HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses

EMBO Molecular Medicine

Volumn 2, Issue 6, 2010, Pages 231-244

  Haas, Anna ^a   Rehr, Manuela ^a   Graw, Frederik ^a   Rusert, Peter ^b   Bossart, Walter ^b   Kuster, Herbert ^c   Trkola, Alexandra ^b   Günthard, Huldrych F ^c   Oxenius, Annette ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CD4+ T cells; Chronic immune activation; Dendritic cells; Herpes viruses; HIV pathogenesis

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; VIRUS ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; VIRUS REPLICATION; FEMALE; HERPESVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; HERPESVIRIDAE; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED;

EID: 77954611567     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201000075     Document Type: Article

References (48)

1. Bangs SC, McMichael AJ, Xu X-N (2006) Bystander T cell activation- implications for HIV infection and other diseases. Trends Immunol 27: 518-524
2. Bangs SC, Baban D, Cattan HJ, Li CK-F, McMichael AJ, Xu X-N (2009) Human CD4+ memory T cells are preferential targets for bystander activation and apoptosis. J Immunol 182: 1962-1971
3. Barron M, Blyveis N, Palmer B, MaWhinney S, Wilson C (2003) Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 187: 26-37
4. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al (2007) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371
5. Caron G, Duluc D, Fremaux I, Jeannin P, David C, Gascan H, Delneste Y (2005) Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-ψ production by memory CD4production by memory T cells. J Immunol 175: 1551-1557
6. Compston LI, Sarkobie F, Li C, Candotti D, Opare-Sem O, Allain J-P (2008) Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods 151: 47-54
7. Dillon SM, Robertson KB, Pan SC, Mawhinney S, Meditz AL, Folkvord JM, Connick E, McCarter MD, Wilson CC (2008) Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 48: 1-12
8. Doisne J-M, Urrutia A, Lacabaratz-Porret C, Goujard C, Meyer L, Chaix M-L, Sinet M, Venet A (2004) CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 173: 2410-2418
9. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, Casazza JP, Kuruppu J, Kunstman K, Wolinsky S, et al (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95-98
10. Douek DC, Picker LJ, Koup RA (2003) T cell dynamics in HIV-1 infection. Annu Rev Immunol 21: 265-304
11. Dubin JA, Mueller H-G (2005) Dynamical correlation for multivariate longitudinal data. J Am Stat Assoc 100: 872-881
12. Edelman DC (2005) Human herpesvirus 8-a novel human pathogen. Virol J 2: 78
13. Fonteneau J-F, Larsson M, Beignon A-S, McKenna K, Dasilva I, Amara A, Liu Y-J, Lifson JD, Littman DR, Bhardwaj N (2004) Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 78: 5223-5232
14. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, Shih R, Lewis J, Wiley DJ, Phair JP, et al (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870
15. Griffin E, Krantz E, Selke S, Huang M-L, Wald A (2008) Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons. JMed Virol 80: 1153-1159
16. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ (2006) Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12: 289-295
17. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004a) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1- infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966-972
18. Harari A, Vallelian F, Pantaleo G (2004b) Phenotypic heterogeneity of antigenspecific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol 34: 3525-3533
19. Haring JS, Badovinac VP, Harty JT, (2006) Inflaming the CD8+ T cell response. Immunity 25: 19-29
20. Harman AN, Wilkinson J, Bye CR, Bosnjak L, Stern JL, Nicholle M, Lai J, Cunningham AL (2006) HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 177: 7103-7113
21. Havenar-Daughton C, Kolumam GA, Murali-Krishna K (2006) Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 176: 3315-3319
22. Jones L, Black Antony P, Malavige Gathsaurie N, Ogg Graham S (2007) Phenotypic analysis of human CD4 T cells specific for immediate early 63 protein of varicella-zoster virus. Eur J Immunol 37: 3393-3403
23. Kabelitz D (2007) Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol 19: 39-45
24. Kaiser P, Joos B, Niederost B, Weber R, Gunthard HF, Fischer M, the Swiss HIV Cohort Study (2007) Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 doublenegative T lymphocytes. J Virol 81: 9693-9706
25. Karrer U, Sierro S, WagnerM, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P (2003) Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 170: 2022-2029
26. Kaur A, Kassis N, Hale CL, Simon M, Elliott M, Gomez-Yafal A, Lifson JD, Desrosiers RC, Wang F, Barry P, et al (2003) Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS. J Virol 77: 5749-5758
27. Komatsu H, Sierro S, Cuero AV, Klenerman P (2003) Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin Exp Immunol 134: 9-12
28. Lederer S, Favre D, Walters K-A, Proll S, Kanwar B, Kasakow Z, Baskin CR, Palermo R, McCune JM, Katze MG (2009) Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 5: e1000296
29. Lore K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, Roederer M, Seder RA, Koup RA (2003) Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 171: 4320-4328
30. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14: 1077-1087
31. Oxenius A, Price DA, Easterbrook PJ, O'Callaghan CA, Kelleher AD, Whelan JA, Sontag G, Sewell AK, Phillips RE (2000) Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci USA 97: 3382-3387
32. Pape K, Khoruts A, Mondino A, Jenkins M (1997) Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J Immunol 159: 591-598
33. Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ (1999) HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5: 518-525
34. Rawson PM, Molette C, Videtta M, Altieri L, Franceschini D, Donato T, Finocchi L, Propato A, Paroli M, Meloni F, et al (2007) Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med 13: 1431-1439
35. Redd AD, Dabitao D, Bream JH, Charvat B, Laeyendecker O, Kiwanuka N, Lutalo T, Kigozi G, Tobian AAR, Gamiel J, et al (2009) Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci USA 106: 6718-6723
36. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK (2008) Murine model of cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325: 315-331.
37. Silvestri G, Feinberg MB (2003) Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest 112: 821-824
38. Smed-Sorensen A, Lore K, Vasudevan J, Louder MK, Andersson J, Mascola JR, Spetz A-L, Koup RA (2005) Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 79: 8861-8869
39. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB (2008) Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29: 650-659
40. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RMM (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169: 3400-3406
41. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, et al (2009) Induction of a striking systemic cytokine cascade prior to peak viraemia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719-3733
42. Tilton JC, Manion MM, Luskin MR, Johnson AJ, Patamawenu AA, Hallahan CW, Cogliano-Shutta NA, Mican JM, Davey RT, Jr, Kottilil S, et al (2008) Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol 82: 3997-4006
43. Torre-Cisneros J, del Castillo M, Caston JJ, Castro MC, Perez V, Collantes E (2005) Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis. Rheumatology 44: 1132-1135
44. Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C, Manrique A, Huber M, Rehr M, Oxenius A, et al (2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11: 615-622
45. Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ (1997) Determination of antigen-specificmemory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 99: 1739-1750
46. Way SS, Havenar-Daughton C, Kolumam GA, Orgun NN, Murali-Krishna K (2007) IL-12 and type-I IFN synergize for IFN-γ production by CD4 T cells, whereas neither are required for IFN-g production by CD8 T cells after Listeria monocytogenes infection. J Immunol 178: 4498-4505
47. Yun Z, Lewensohn-Fuchs I, Ljungman P, Vahlne A (2000) Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction. Transplantation 69: 1733-1736
48. Zingg W, Bossart W, Berli E, Nadal D (1999) Detection and quantification of cell-free Epstein-Barr virus by polymerase chain reaction and subsequent DNA enzyme immunoassay. J Virol Methods 79: 141-148